# Carbon Ions Radiation Therapy for Resectable or Borderline Resectable Pancreas Adenocarcinoma

> **NCT03822936** · PHASE2 · TERMINATED · sponsor: **CNAO National Center of Oncological Hadrontherapy** · enrollment: 30 (actual)

## Conditions studied

- Cancer of Pancreas
- Pancreas Adenocarcinoma
- Resectable Pancreatic Cancer

## Interventions

- **DRUG:** Preoperative chemotherapy
- **RADIATION:** Preoperative radiotherapy

## Key facts

- **NCT ID:** NCT03822936
- **Lead sponsor:** CNAO National Center of Oncological Hadrontherapy
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-02-08
- **Primary completion:** 2022-08-08
- **Final completion:** 2025-02-10
- **Target enrollment:** 30 (ACTUAL)
- **Why stopped:** The study was early closed due to low accrual in August 2022.
- **Last updated:** 2025-02-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03822936

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03822936, "Carbon Ions Radiation Therapy for Resectable or Borderline Resectable Pancreas Adenocarcinoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03822936. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*